Searched for
GLAND PHARMA SALE
Gland Pharma shares jump 11% as Q4 profit soars 97% YoY, co announces Rs 20/share final dividendShares of Gland Pharma rallied on Monday after the company reported a 97% YoY surge in Q4 profit and strong revenue growth, driven by its C...
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
Gland Pharma shares tumble over 3% after Fosun Pharma likely sells 6.2% stake via block dealShares of Gland pharma fell 3.7% as Shanghai-based Fosun Pharma offloaded a 6.2% stake in a block deal managed by UBS, decreasing its holdi...
Fosun is said to plan block deals to pare stake in Gland PharmaThe listed arm of billionaire Guo Guangchang’s Fosun International Ltd. holds about 58% of Gland Pharma, which has a market value 303 billi...
Two entities likely to sell 4.4% stake in Gland Pharma via block deals: ReportNicomac Machinery and RP Advisory Services are looking at raising Rs 1,400 crore through the sale, and have set the floor price for the sam...
Morgan Stanley offloads stake in this pharma stock via bulk dealMorgan Stanley Investment Funds Emerging Markets Equity Fund has sold a 0.58% stake in Gland Pharma via open market transactions. The sell-...
Fosun drops plan to sell stake in Gland Pharma: ReportShares of Gland Pharma were up 0.8% at 1,360 rupees as of 9:50 a.m. IST. They have plunged 28% since November end, when Bloomberg News had ...
Gland Pharma falls 5% after announcing Cenexi Group acquisitionCenexi, along with its subsidiaries, is engaged primarily in the business of Contract Development & Manufacturing Organisation (CDMO) of ph...
Gland says not heard from its promoter Fosun about the potential saleThe debt-laden Chinese conglomerate Fosun controlled by billionaire entrepreneur Guo Guangchang has been looking to sell non-core assets, t...
Fosun Said to Mull Sale of India’s $3.6 Billion Gland PharmaA sale would help Gland’s Chinese owner raise cash as the once-acquisitive group seeks to shore up its balance sheet. Fosun International h...
Gland Pharma rallies 9% as Fosun mulls selling controlling stake in firmA sale would help Gland’s Chinese owner raise cash as the once-acquisitive group seeks to shore up its balance sheet. Fosun International h...
Hold Gland Pharma, target price Rs 2100: Axis SecuritiesGland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 31075.06 Crore) operating in Pharmaceut...
Buy Gland Pharma, target price Rs 4930: Emkay GlobalGland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 54853.29 Crore) operating in Pharmaceut...
Buy Gland Pharma, target price Rs 4930: Emkay GlobalGland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 54285.62 Crore) operating in Pharmaceut...
Buy Gland Pharma, target price Rs 5000: Emkay GlobalGland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 60468.02 Crore) operating in Pharmaceut...
Buy Gland Pharma, target price Rs 5000: Emkay GlobalGland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 59158.23 Crore) operating in Pharmaceut...
Buy Gland Pharma, target price Rs 2900: Motilal OswalMotilal Oswal has a buy call on Gland Pharma with a target price of Rs 2900. The current market price of Gland Pharma is Rs 2652.95.
Chinese firm-backed Gland Pharma files for IPO; may raise up to Rs 6,000 croreThe company may raise up to $800 million or Rs 6,000 crore, a source with the knowledge of the matter said.
Fosun Pharma acquires 74% stake in Gland Pharma for $1.09 billionFosun Pharma and Fosun International indirectly hold approximately 74 per cent equity interest in Gland Pharma, the joint statement added.
Government clears KKR's proposal to buy stakes in Gland Pharma and Gland Celsus Bio ChemicalsGland Pharma makes and markets specialised injectable formulations for generic versions of drugs, it also manufactures a limited quantity o...